标准化多草药配方在2型糖尿病管理中的验证:一个随机,双盲,安慰剂控制的随机试验
Shridhar Pandya1, Chetan Savaliya1, Kamlesh Thummar1
1Gplife Healthcare Pvt Ltd, 705‑706, Orbit‑ 1 Building, Punagam‑Saroli Rd, Near RRTM Market, 395010 Surat, India.
Journal of diabetes and metabolic disorders
|May 31, 2023
概括
这项研究表明,糖尿病支持产品 (GP/PROD/2021/001) 显著改善了2型糖尿病标志物,如HbA1c,并减少了药物依赖. 它为糖尿病管理提供了一个更安全,更有效的辅助疗法.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
背景情况:
- 糖尿病是一种全球性的健康问题,印度是成人糖尿病患病率最高的国家之一.
- 传统的抗糖尿病药物和胰岛素可以引起显著的副作用.
- 植物成分为血糖调节和减少对药物干预的依赖提供了一个有希望的途径.
研究的目的:
- 评估糖尿病支持产品 (GP/PROD/2021/001) 作为2型糖尿病的辅助疗法的临床疗效.
- 评估GP/PROD/2021/001对关键血糖控制标志物和胰岛素抵抗的影响.
主要方法:
- 这是一项90天的随机,双盲,安慰剂对照试验,涉及150名2型糖尿病患者.
- 参与者每天接受GP/PROD/2021/001或安慰剂,每天两次,除了他们的标准药物.
- 主要结局包括禁食血葡萄糖 (FBS),饭后血葡萄糖 (PPBS) 和HbA1c水平的变化.
主要成果:
- 与安慰剂相比,GP/PROD/2021/001在90天内显示出HbA1c,FBS和PPBS的显著改善.
- 在GP/PROD/2021/001组与安慰剂组 (6.21%) 相比,观察到HbA1c水平显著降低 (23.51%).
- 降低的HOMA-IR得分表明胰岛素敏感性有所改善,治疗组中报告有改善的生活质量.
结论:
- 糖尿病支持产品 (GP/PROD/2021/001) 是一种安全有效的辅助剂,用于新诊断和慢性患者的2型糖尿病管理.
- 该产品有助于减少对传统抗糖尿病药物和胰岛素的依赖.
- GP/PROD/2021/001 是糖尿病综合护理中一个有价值的治疗选择.
相关概念视频
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
241
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
241
Insulin Formulations: Types and Delivery
239
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
239
Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K


